Dr. John Cush RheumNow
6 years 6 months ago
Using 1987 ACR Criteria, Mayo clinic finds a significant increase in incidence of RF-negative RA and decrease in RF-positive RA in 2005–2014 compared with previous decades. Smoking has decreased and obesity increased in recent years. https://t.co/KZ8DqhOyUe
It is not hyperbole to acknowledge that the COVID-19 pandemic has changed the world, inflicting pain and suffering to many, and inconvenience to all. As everyone struggles to make it through these difficult times, it might be worth pointing out some small silver linings that have emerged despite this pernicious dark cloud.
Dr. John Cush RheumNow
6 years 6 months ago
ACR president-elect Dr. David Karp answers questions about hydroxychloroquine and COVID-19; interview, transcript and video. https://t.co/7dRzr1ke89
Dr. John Cush RheumNow
6 years 6 months ago
RheumNow interviews Dr @philipcrobinson about the rapid growth/impact of the COVID-Global Rheumatology Alliance Registry & how you can join and enroll your rheum patients with suspected COVID. https://t.co/pOlm58QkZD or podcast here> https://t.co/G2otSrIG1U
Dr. John Cush RheumNow
6 years 6 months ago
A PODCAST - Rheum Patient PSA on how to manage your arthritis, meds, biologics, misinformation, safety and STRESS in the time of COVID-19 (a 44:01 minute compilation of 5 PSA podcasts) https://t.co/ENrORXRDqz
Dr. John Cush RheumNow
6 years 6 months ago
RheumNow PSA 1 -- How to Manage your Arthritis Medications (in the time of COVID) - View the video here: https://t.co/egUTpxfx96 or listen to the podcast on iTunes or here>> https://t.co/8wV4V2pYY5
The COVID-19 Global Rheumatology Alliance rheum_covid
6 years 6 months ago
Listen to Dr. Jack Cush from @RheumNow interview @philipcrobinson about The COVID-19 Global Rheumatology Alliance
https://t.co/aZLsZnAoP3
Drugs.com Drugscom
6 years 6 months ago
Lilly's Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis - https://t.co/kDbNqo2Pii
Dr. Janet Woodcock DrWoodcockFDA
6 years 6 months ago
Be careful, QT prolongation is a known effect of chloroquine and hydroxychloroquine. Could be worsened when used with azithromycin. Death and problems reported from France. https://t.co/sKekD9A8Yt
COVID-19 Global Rheumatology Alliance Big Start
Interview with Dr. Philip Robinson, Univ. of Queensland
The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections. Below are experts from that report.
Dr. John Cush RheumNow
6 years 6 months ago
Survival in lung cancer patients with RA is less than that of those without RA (worse w/ RA-ILD). Study of a cohort 154 lung CA pts (18 with RA,136 without RA) compared propensity matched 18 RA vs 36 without RA and Lung CA. https://t.co/zint9QICE1
Dr. John Cush RheumNow
6 years 6 months ago
NEJM article on renin-angiotensin-aldosterone inhibitors may increase ACE2 & Covid-19 binding but, "Insufficient data available to determine whether observations translate to humans...no studies have evaluated ...RAAS inhib in Covid-19" https://t.co/x39oCgRTp1
Dr. Ramon Grimalt DrRamonGrimalt
6 years 6 months ago
#Skin Manifestations in #COVID19.
A very recent article appeared in the @TheJEADV regarding the #dermatological findings in #Covid_19 infection in #Italy.
The authors report that (20.4%) developed cutaneous manifestations. More info ... 👇 #dermatology https://t.co/r1CVcbIUUJ
